IL-23 is a proinflammatory cytokine in the TME that mediates the infiltration of M2 macrophages and neutrophils while inducing immunosuppression by reducing the infiltration of CD4+ and CD8+T cells into tumor tissues48. The gene discussed is IL23A; the disease is neoplasm.